Timothy K. Lu - 09 Mar 2026 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Signature
/s/ Robert Cutler, attorney-in-fact
Issuer symbol
SNTI
Transactions as of
09 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 16:01:30 UTC
Previous filing
03 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lu Timothy K CEO, Director C/O SENTI BIOSCIENCES, INC., 2 CORPORATE DRIVE FIRST FLOOR, SOUTH SAN FRANCISCO /s/ Robert Cutler, attorney-in-fact 09 Mar 2026 0001852301

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNTI Common Stock Tax liability -80,666 -11% $0.000000* 639,583 09 Mar 2026 Direct F1
holding SNTI Common Stock 52,839 09 Mar 2026 By spouse
holding SNTI Common Stock 52,839 09 Mar 2026 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale.
F2 The shares are held by Luminen Services, LLC, as trustee of the Luminen Trust, of which the reporting person is the settlor. The reporting person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.